Fisetin was shown to inhibit phosphorylation of MEK1/2 and ERK1/2 in the MAPK signaling pathway activation pathway and inhibit NFκB in signaling to reduce melanoma A375 cell invasion and metastasis. The gene discussed is MAP2K1; the disease is melanoma.